ABC -- A generation of baby boomers is approaching retirement and Americans are living longer. But elderly people are routinely left out of clinical drug trials that determine how people react to medications, according to a new report. The report released this week by Houston’s Baylor College of Medicine and the Intercultural Cancer Council found that studies focused on drugs for diseases affecting the elderly -- whether Alzheimer’s, arthritis or cancer -- are conducted without much participation from older Americans.
